Oxford Immunotec Edges Closer To Transplant Product Launch
Oxford Immunotec has set its sights on a 2017 launch for two new immune-response tests emerging from its T-spot platform, on the back of interim results from a major clinical study due at the end of Q1.
You may also be interested in...
Oxford Immunotec has appointed Karen Koski as its head of strategy and investor relations. Koski joins the company as it prepares to launch this year two new tests from its T-spot platform.
Oxford Immunotec, an immunology-focused diagnostics company, has acquired US company Immunetics.
Experts from the University of Chicago are advocating for helmet ventilation for COVID-19 patients. Medtech Insight spoke to acute nurse practitioner Aurika Savickaite who is helping lead an initiative to educate and raise awareness of the technology.